Paid Clinical Trials in Tulsa, OK
As of September 2026, 173 paid clinical trials are recruiting in Tulsa, Oklahoma. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Tulsa offers studies at sites including Laureate Institute for Brain Research for conditions such as Heart Failure, Breast Cancer, Alzheimer Disease, Aortic Valve Stenosis. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Tulsa
Trials by drug in Tulsa
Filter results
Newly added in Tulsa
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Pedal Pump Clinical Trial on Edema V2
A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Pedal Pump Clinical Trial on Edema V1
159 clinical trials
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
A Study of Buntanetap in Participants With PD
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Assessment of CCM in HF With Higher Ejection Fraction
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Strategy for Improving Stroke Treatment Response
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Top Research Study Locations in Tulsa
Researchers run research studies in Tulsa, OK at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Laureate Institute for Brain Research | Depression, Alcohol Use Disorder, Anorexia Nervosa | 11 |
| Saint Francis Children's Hospital | Mixed Phenotype Acute Leukemia, Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma | 11 |
| Oklahoma Heart Institute | Aortic Valve Stenosis, Heart Failure, Heart Failure With Mid Range Ejection Fraction | 10 |
| Oklahoma Cancer Specialists and Research Institute, LLC | Cervical Cancer, HPV Positive Oropharyngeal Squamous Cell Carcinoma, HPV-Related Cervical Carcinoma | 9 |
| DelRicht Research | Chronic Pain, Osteoarthritis, Knee, Acute Gout Flare | 7 |
| Oklahoma Cancer Specialists and Research Institute-Tulsa | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8 | 7 |
| Saint Francis Hospital | AMI Cardiogenic Shock, Acute Lower Limb Arterial Occlusion, Atrial Fibrillation | 7 |
| Central States Research | Alzheimer Disease, Acute Treatment of Migraine, Dementia | 6 |
| The Movement Disorder Clinic of Oklahoma | Lewy Body Dementia Psychosis, Parkinson Disease, Deep Brain Stimulation | 6 |
| Oklahoma Cancer Specialists and Research Institute | Breast Cancer, Endometrial Cancer, Melanoma | 5 |
| Ascension St. John | Ischemic Stroke, Stroke, Acute Stroke | 4 |
| GSK Investigational Site | Chickenpox, Influenza, Human, Irritable Bowel Syndrome | 4 |
| Hillcrest Medical Center | Lower Extremity Edema, Aortic Valve Disease, Aortic Valve Stenosis | 4 |
| Tulsa Retina Consultants | Age-Related Macular Degeneration, Age-related Macular Degeneration (AMD), Choroidal Neovascularization | 3 |
| Ascension St. John Clinical Research Institute | Peripheral Vascular Diseases, Symptomatic Hypertrophic Cardiomyopathy (HCM) | 2 |
| Ascension St. John Medical Center | Atrial Fibrillation, Coagulation Disorder, Intracerebral Hemorrhage | 2 |
| Oklahoma Heart Institute at Hillcrest Medical Center | Coronary Artery Disease, Tricuspid Regurgitation, Tricuspid Valve Disease | 2 |
| Options Health Research | Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis, Metabolic Dysfunction Associated Steatohepatitis (MASH) | 2 |
| St. John Medical Center | Intracerebral Hemorrhage, Atrial Fibrillation | 2 |
| Stephenson Cancer Center- Tulsa | Breast Cancer, Lymphoma, Pancreas Cancer | 2 |
| University of Oklahoma - Schusterman Center | Pain, Discrimination, Racial, Smoking (Tobacco) Addiction | 2 |
| University of Oklahoma Health Campus | Prediabetes, Smoking, Cigarette | 2 |
| University of Oklahoma Schusterman Center - Tulsa | Alcohol Drinking, Binge Drinking, Chronic Pain Due to Cancer | 2 |
| Vital Prospects Clinical Research Institute | Chronic Rhinosinusitis Without Nasal Polyps, Chronic Spontaneous Urticaria (CSU) | 2 |
| Vital Prospects Clinical Research Institute, PC | Alopecia Areata, Atopic Dermatitis | 2 |
Active & Upcoming Studies in Tulsa (2026)
Recruiting trials in Tulsa grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (40 active studies)
- Feasibility and Acceptability of Empowered Relief for American Indians With Pain During and After Cancer Treatment · University of Oklahoma
- Empowered Relief® for Cancer Survivors With Chronic Pain · University of Oklahoma
Neurology & pain (22 active studies)
- Feasibility and Acceptability of Empowered Relief for American Indians With Pain During and After Cancer Treatment · University of Oklahoma
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain · Phase 2 · Eli Lilly and Company
Cardiovascular (17 active studies)
- Pedal Pump Clinical Trial on Edema V2 · Hillcrest
- Pedal Pump Clinical Trial on Edema V1 · David McVay
Mental health & behavior (14 active studies)
- FLOAT for Healthcare PTSS · EARLY_Phase 1 · Laureate Institute for Brain Research, Inc.
- Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT) · Bristol-Myers Squibb
Diabetes & metabolic (8 active studies)
- A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes · Phase 3 · Eli Lilly and Company
- A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity · Phase 3 · Eli Lilly and Company
Eye & vision (3 active studies)
- A Phase 2 Study of NT-101 Topical in Patients With Wet AMD · Phase 2 · NexThera Co., Ltd.
- A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) · Phase 2, Phase 3 · EyeBiotech Ltd.
Vaccines (2 active studies)
- A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age · Phase 3 · GlaxoSmithKline
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry · Massive Bio, Inc.
Common conditions studied in Tulsa
- Heart Failure (6 active studies)
- Breast Cancer (4 active studies)
- Alzheimer Disease (3 active studies)
- Aortic Valve Stenosis (3 active studies)
- Atopic Dermatitis (3 active studies)
- Cancer (3 active studies)
Leading research sponsors in Tulsa
- University of Oklahoma
- Laureate Institute for Brain Research, Inc.
- Eli Lilly and Company
- AstraZeneca
- Merck Sharp & Dohme LLC
Frequently asked questions
How many paid clinical trials are currently recruiting in Tulsa?
There are approximately 173 recruiting clinical trials in Tulsa, Oklahoma listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Tulsa pay participants?
Most recruiting trials in Tulsa compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Tulsa?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Tulsa?
The most common conditions under active study in Tulsa include Heart Failure (6), Breast Cancer (4), Alzheimer Disease (3), Aortic Valve Stenosis (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Tulsa?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Tulsa on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Tulsa?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Tulsa?
Recruiting research sites in Tulsa include Laureate Institute for Brain Research, Saint Francis Children's Hospital, Oklahoma Heart Institute, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Tulsa right now?
The largest active categories in Tulsa are Cancer & tumors (40), Neurology & pain (22), Cardiovascular (17). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.